HR6166Referred to Committee

Lowering Drug Costs for American Families Act

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2025-11-20
Introduced
55
Cosponsors
HR
Type

Sponsor

Frank Pallone, Jr.
Frank Pallone, Jr.
Democrat · NJ · Representative
Votes with party: 97.9% (605 recorded votes)

Full profile: /officials/P000034

Source: Congress.gov · FEC

Cosponsors (55)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

2025-11-20

Source: Congress.gov

Committee Activity

Currently in

Previously

Plain-English Summary

This bill aims to reduce what Americans pay for prescription medications through various policy changes, though the specific measures haven't been detailed yet since it's still in the early committee review stage. The proposal would likely affect patients who buy drugs, pharmaceutical companies that manufacture them, and possibly insurance companies and healthcare providers involved in drug pricing. Once the relevant committees examine their portions of the bill, they'll determine what tools—such as price negotiations, generic drug incentives, or out-of-pocket cost limits—would actually be used to bring down drug prices.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Subjects

Health
Full bill text is not yet cached locally.